← Browse by Condition
Medical Condition

pids linked to pi3k

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for pids linked to pi3k sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2
1
Top Sponsors
Pharming Technologies B.V. 1 trial
NCT06990529 Phase 2
Recruiting

Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation

Enrollment
12 pts
Location
United States, Spain
Sponsor
Pharming Technologies B.V.
View Trial →